JPRN-UMIN000028605
Completed
未知
A retrospective study for ALK positive Lung Cancer - The Clinical Benefits of Sequential Therapy using Crizotinib followed by Alectinib in Clinical Practice: A Multicenter Retrospective Study. - (WJOG9516L) - A retrospective study for ALK positive Lung Cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- West Japan Oncology Group
- Enrollment
- 700
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •No prior exposure of ceritinib before crizotinib or alectinib, regardless of clinical trial or practice.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A retrospective analysis on the lung cancer specimens for Oncomine Dx Target Test in Keio University Hospitalon-small cell lung cancer (NSCLC)JPRN-UMIN000050424Keio University School of Medicine500
Completed
Not Applicable
Clinical study on the treatment of lung cancer related fatigue with deficiency of Qi-blood by traditional Chinese herb medicine combined with AcupunctureITMCTR2000003964Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Recruiting
Not Applicable
trecht COhort for Lung cancer Outcome Reporting and trial inclusion (U-COLOR)Lung cancer10038666NL-OMON54999niversitair Medisch Centrum Utrecht3,200
Completed
Not Applicable
tritional Assessment in Non-small Cell lung cancer patientslungcancerNon Small Cell Lung Cancer10038666NL-OMON50451Antoni van Leeuwenhoek Ziekenhuis100
Completed
Not Applicable
Treatment of lung cancer - a health care research study using data cancer registry data (registration according to § 65c SGB V)C34Malignant neoplasm of bronchus and lungDRKS00025080niversität zu Lübeck, Institut für Sozialmedizin und Epidemiologie70,804